Navi
Right
 
Skip Navigation LinksHome Research report list Pharma & Healthcare Healthcare Global Hemophilia Market: Industry Analysis & Outlook (2017-2021)
 
Social
Global Hemophilia Market: Industry Analysis & Outlook (2017-2021)
Format : Pdf (Instant Download)
Date: 27, March 2017 | Pages: 86
Social
 
Electronic Access - Single User License
Tool
USD 800
Electronic Access - Corporate User License
Tool
USD 1100
Hard Copy - Mail Delivery
Tool
USD 875
 
   
 

The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causes abnormal bleeding with poor clotting. It is classified into hemophilia A, hemophilia B, hemophilia C, and hemophilia with inhibitors.

 

Treatment for hemophilia is done via replacement therapy, prophylactic therapy, on-demand therapy, gene therapy and many others. Gene therapy is being regarded as an attractive option for treatment of hemophilia. By the year 2030, the pharmaceutical companies are expected to launch their gene therapy treatment for hemophilia, and this might affect the market dynamics at large.

 

The growth factors of the hemophilia market include increased focus on prophylactic treatment, growing market for FVIII, increasing diagnosis rate, and increasing healthcare expenditure. Major trends of the market include development of novel hemophilia treatment, subcutaneous dosing and growing popularity of gene therapy. Further, growth prospects are hindered by high cost of therapy and consumer’s reluctance in switching to new therapy options.

 

The report offers an in-depth analysis of the global hemophilia market. It also covers the global as well as regional aspect of the market. The top notch players in the market exhibit a very close competition. The report profiles Pfizer Inc., Bayer Group, Shire PLC, and Novo Nordisk.
 

 

1. Market Overview

 

1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis & Treatment

 

2. Global Market Analysis

 

2.1 Global Hemophilia Market by Value
2.2 Global Hemophilia Market Forecast by Value
2.3 Global Hemophilia Market by Therapeutic Class
2.3.1 Global Hemophilia Traditional Factors Market Forecast by Value
2.4 Global Hemophilia Market by Type
2.4.1 Global Hemophilia A Market Forecast by Value
2.4.2 Global Hemophilia A Market Forecast by Therapeutic Class
2.4.3 Global Hemophilia A Market by Severity
2.4.4 Global Hemophilia with Inhibitors Market Forecast by Value
2.4.5 Global Hemophilia B Market Forecast by Value
2.4.6 Global Hemophilia B Market Forecast by Therapeutic Class
2.4.7 Global Hemophilia B Market by Severity

 

3. Regional Market Analysis

 

3.1 The US
3.1.1 The US Hemophilia Market by Value
3.1.2 The US Hemophilia Market Forecast by Value
3.1.3 The US Hemophilia Market by Type
3.1.4 The US Hemophilia A Market Forecast by Value
3.1.5 The US Hemophilia A Market-Treated Patient Volume Forecast
3.1.6 The US Hemophilia A Market-Pediatric Patients Volume Forecast
3.1.7 The US Hemophilia A Market- Adult Patients Volume Forecast
3.1.8 The US Hemophilia B Market Forecast by Value
3.1.9 The US Hemophilia B Market-Treated Patient Volume Forecast

 

3.2 Europe
3.2.1 Europe’s Hemophilia Market- Patient Volume Forecast
3.2.2 Europe’s Hemophilia A Market- Patient Volume Forecast
3.2.3 Europe’s Hemophilia B Market- Patient Volume Forecast

 

4. Market Dynamics

 

4.1 Growth Drivers
4.1.1 Increased Focus on Prophylactic Treatment
4.1.2 Growing Market for FVIII
4.1.3 Increasing Diagnosis Rate
4.1.4 Increasing Healthcare Expenditure

 

4.2 Key Trends
4.2.1 Development of Novel Hemophilia Treatments
4.2.2 Subcutaneous Dosing
4.2.3 Increasing Demand for Recombinant Versions of Factor VIII & FIX Drugs
4.2.4 Popularity of Gene Therapy

 

4.3 Challenges
4.3.1 High Cost of Treatment
4.3.2 Reluctance to Switch to New Therapies

 

5. Competitive Landscape

 

5.1 Global Hemophilia Market
5.1.1 Revenue and Market Cap Comparison
5.2 Global Hemophilia A Market
5.2.1 Market Share
5.2.2 Factor VIII Products Market Share
5.2.3 Factor VIII Gene Therapy Market Share Forecast
5.3 Global Hemophilia B Market
5.3.1 Market Share
5.3.2 Factor IX Products Market Share Forecast
5.3.3 Factor IX Gene Therapy Market Share Forecast

 

6. Company Profiles

 

6.1 Pfizer Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

 

6.2 Bayer Group
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

 

6.3 Shire PLC
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

 

6.4 Novo Nordisk
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Charts

 

Depiction of Inheritance of Hemophilia
Types of Hemophilia
Global Hemophilia Market by Value (2012-2016)
Global Hemophilia Market Forecast by Value (2017-2021)
Global Hemophilia Market by Therapeutic Class (2016- 2030)
Global Hemophilia Traditional Factors Market Forecast by Value (2016-2021)
Global Hemophilia Market by Type (2016)
Global Hemophilia A Market Forecast by Value (2016-2021)
Global Hemophilia A Market Forecast by Therapeutic Class (2016- 2030)
Global Hemophilia A market by Severity (2016)
Global Hemophilia with Inhibitors Market Forecast by Value (2016-2021)
Global Hemophilia B Market Forecast by Value (2016-2021)
Global Hemophilia B Market Forecast by Therapeutic Class (2016- 2030)
Global Hemophilia B Market by Severity (2016)
The US Hemophilia Market by Value (2012-2016)
The US Hemophilia Market Forecast by Value (2017-2021)
The US Hemophilia Market by Type (2016)
The US Hemophilia A Market Forecast by Value (2016-2021)
The US Hemophilia A Market-Treated Patient Volume Forecast (2016-2021)
The US Hemophilia A Market-Pediatric Patients Volume Forecast (2016-2021)
The US Hemophilia A Market- Adult Patients Volume Forecast (2016-2021)
The US Hemophilia B Market Forecast by Value (2016-2021)
The US Hemophilia B Market-Treated Patient Volume Forecast (2016-2021)
Europe’s Hemophilia Market- Patient Volume Forecast (2016-2021)
Europe’s Hemophilia A Market- Patient Volume Forecast (2016-2021)
Europe’s Hemophilia B Market- Patient Volume Forecast (2016-2021)
Market Share of Hemophilia A Patients on Prophylaxis in the US (2014-2016)
Market Share of Hemophilia B Patients on Prophylaxis in the US (2014-2016)
Global Hemophilia A Factor VIII Products Market by Value (2016-2021)
Global Identified Hemophilia Patients Volume (2005-2016)
Global Healthcare Expenditure (2012-2016)
Global Hemophilia A Market Share by Company (2016)
Global Hemophilia A Factor VIII Products Market Share by Company (2021/2030)
Global Hemophilia A FVIII Gene Therapy Market Share Forecast (2030)
Global Hemophilia B Market Share by Company (2016)
Global Hemophilia B Factor IX Products Market Share Forecast (2021/2030)
Global Hemophilia B Factor IX Gene Therapy Market Share Forecast (2030)
Pfizer Inc.'s Revenue Share by Major Business Segment (2016)
Pfizer Inc.’s Revenue and Net Income (2012-2016)
Pfizer Inc. R&D Expenses (2015-2016)
Bayer Group’s Net Sales Share by Business Segments (2016)
Bayer Group’s Net Sales and Net Income (2012-2016)
Shire PLC’s Revenue Share by Franchise (2016)
Shire PLC’s Revenue and Net Income (2012-2016)
Novo Nordisk’s Net Sales Share by Business Segments (2016)
Novo Nordisk’s Net Sales and Net Profit (2012-2016)

 

List of Tables

 

Signs & Symptoms of Hemophilia
Development of New Novel Hemophilia Treatments (2016)
Developed and Upcoming Long Acting Factor VIII Drugs
Factor IX Products in Development
Upcoming Hemophilia Gene Therapy Candidates (2016-2030)
Global Hemophilia Revenue & Market Cap Comparison by Key Players (2016)
Major Business Segments of Pfizer Inc.
Major Products Developed by Pfizer Inc. (Since November 1, 2016)
Bayer Group’s R&D Expenses by Business Segments (2016)
Shire PLC’s Major Product Approvals & Launches (2016)
Shire PLC’s Major Product Pipeline (2016)
Novo Nordisk’s Research and Development (2014-2016)
Novo Nordisk’s Product Pipeline (2016)

One can also purchase any particular sections from this report. Please send us an email to info@konceptanalytics.com with your order details.
 
 
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.